NCT06540300

Brief Summary

Non-suicidal self-injury (NSSI) refers to a series of direct and consequently repeated injuries to one's body without suicidal intent. At present, it has become an important issue of mental disorders. This article focuses on the formation mechanism of NSSI and the intervention effect of rTMS on NSSI patients. At the same time, NSSI patients are collected, a treatment plan is designed to complete a two-week treatment, and the results are analyzed. The aim is to provide theoretical basis for the clinical diagnosis and treatment of NSSI, and also to provide reference for the clinical diagnosis and treatment of NSSI patients.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 30, 2024

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

July 10, 2024

Completed
27 days until next milestone

First Posted

Study publicly available on registry

August 6, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2025

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2025

Completed
Last Updated

August 6, 2024

Status Verified

August 1, 2024

Enrollment Period

11 months

First QC Date

July 10, 2024

Last Update Submit

August 1, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Ottawa Self-injury Inventory

    OSI was evaluated by professionally trained doctors (non experimental intervention) at baseline and two weeks after treatment to assess the effectiveness of the treatment. Comparing the differences in self harm thoughts and behaviors between the baseline period and the intervention group and the control group, p\<0.05 indicates a significant difference.

    2 weeks

  • Magnetic resonance imaging

    2 weeks

Study Arms (2)

Effects of rTMS on NSSI

EXPERIMENTAL

Exploring the effectiveness of rTMS intervention in NSSI patients using the Ottawa Self Injury Scale and other scales as research subjects

Other: rTMS stimulation of right IPL

rs-fMRI-functional connectivity

EXPERIMENTAL

Based on rs fMRI technology, imaging methods were used to analyze the brain images of patients and explore the changes in functional connectivity of brain regions before and after intervention in two groups of subjects.

Other: rTMS stimulation of right IPL

Interventions

The stimulation site is the right IPL (EEG International 10-20 system, electrode CP4/CP6), with a stimulation frequency of 1-Hz and intensity of 100% RMT. There are 50 pulses each time, 20 seconds each cycle, 5 seconds each, with an interval of 15 seconds, for a total of 60 cycles, a total duration of 20 minutes, and a total of 3000 pulses. Perform treatment once a day, rest for 2 days after 5 consecutive days of treatment, for a total of 2 weeks, and receive 10 treatments.

Effects of rTMS on NSSIrs-fMRI-functional connectivity

Eligibility Criteria

Age10 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Meets the NSSI diagnostic criteria recommended in DSM-5;
  • The Chinese version of the Brief International Neuropsychiatric Interview (MINI) screen for diagnostic compliance;
  • Age :10-55 years old;
  • Right hand;
  • The paitent voluntarily participate and sign the informed consent form for this study (signed by participants under the age of 18 and their families);
  • Able to understand written language and cooperate with questionnaire surveys.

You may not qualify if:

  • History of severe substance abuse;
  • The patient has other serious mental disorders, neurological disorders, or physical illnesses; 3、Previously experienced epileptic seizures;
  • 、Pregnant or lactating women; 5、Contraindications to magnetic resonance imaging and transcranial magnetic stimulation; 6、Unable or refused to provide written informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nanjing Brain Hospital

Nanjing, Jiangsu, 210029, China

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study used a randomized, double-blind study method that controlled true and false stimuli. Except for the study leader, neither the actual operators nor the patients themselves knew whether they were receiving real or fake stimuli. A two factor mixed trial design was adopted, with a detection time of 2 (pre stimulus vs post stimulus) x 2 (stimulus type: right IPL vs pseudo stimulus). The stimulus type was an inter subject factor, and the detection time was an intra subject factor. The enrolled NSSI patients were randomly divided into a study group (right IPL group) and a control group (pseudo stimulus group) using a random number table method. Collect general demographic scales, symptom scales, and magnetic resonance imaging data before treatment, and conduct symptom scale retesting and magnetic resonance imaging data collection 2 weeks after treatment.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate chief physician

Study Record Dates

First Submitted

July 10, 2024

First Posted

August 6, 2024

Study Start

June 30, 2024

Primary Completion

May 30, 2025

Study Completion

June 15, 2025

Last Updated

August 6, 2024

Record last verified: 2024-08

Locations